Ricky, Solbec put the news out there. They have so much going for them. They have made countless presentations to brokers. I guess the investment industry are not buying the results so far. Even though no other Australian Biotech drug has seen major durable responses against such late stage cancers. This is rare. The trials they are commencing now I think are against earlier stage cancers and should have a chance of demonstrating even better results. Plus they are against a cancer identified in the previous trial as a good target. They have stated in advance they will release results during the trial. Confidence? You may never see Solbec shares this low again. I think the resources boom has more to do with the low share price of biotechs right now. The first biotech Genentech(Nasdaq:DNA) now has a market cap of 86.5 billion US dollars. Do your own DD Good luck to Solbec holders
SBP Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
